The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
26 05 2022
Historique:
received: 14 04 2022
revised: 20 05 2022
accepted: 25 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces a significant inflammatory response that are amplified by persistent stress. The pathophysiology of mental illnesses is explored in terms of inflammatory processes. Thus, anxious, depressed, or psychotic episodes may occur as a result of metabolic and immunological imbalances, as a direct result of their effect on the central nervous system, or as a side effect of the COVID-19 medication protocols. As such, the primary objective of this research is to establish if the psychological profiles of COVID-19 patients change substantially according to illness severity. The secondary objective is to determine if particular biological inflammatory indicators are associated with anxiety, sadness, psychoticism, and paranoid ideation. A cross-sectional study was performed on 90 hospitalized patients admitted during a 3-month period in the COVID-19 unit. All patients received the COPE-60 and SCL-90R questionnaires. Clinical and paraclinical data were collected and the information was classified according to the severity of COVID-19.The hyper-acute inflammation encountered in patients with severe COVID-19 infection characterized 80.0% of patients using disengagement coping methods, significantly more than patients with mild or moderate SARS-CoV-2 infection severity (

Identifiants

pubmed: 35682084
pii: ijerph19116501
doi: 10.3390/ijerph19116501
pmc: PMC9180708
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Brain Sci. 2021 Sep 28;11(10):
pubmed: 34679351
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
J Clin Med. 2021 Jun 16;10(12):
pubmed: 34208640
Asian J Psychiatr. 2020 Jun;51:102092
pubmed: 32315963
Mol Psychiatry. 2016 Dec;21(12):1696-1709
pubmed: 26903267
Psychiatry Res. 2020 Sep;291:113254
pubmed: 32603930
Dev Psychopathol. 2012 May;24(2):335-44
pubmed: 22559117
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104949
pubmed: 32410807
Psychiatr Danub. 2020 Summer;32(2):245-250
pubmed: 32796793
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22035-22041
pubmed: 32820077
Mol Cell Proteomics. 2021;20:100159
pubmed: 34619366
Neuron. 2020 Jul 22;107(2):234-256
pubmed: 32553197
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Scand J Psychol. 2014 Apr;55(2):142-50
pubmed: 24697686
Int J Soc Psychiatry. 2021 Aug;67(5):540-549
pubmed: 33016171
J Clin Med. 2022 Jan 27;11(3):
pubmed: 35160114
JMIR Ment Health. 2021 Aug 19;8(8):e28736
pubmed: 34254939
J Pers Soc Psychol. 1989 Feb;56(2):267-83
pubmed: 2926629
Ir J Psychol Med. 2020 Sep;37(3):156-158
pubmed: 33043880
Pathogens. 2020 Mar 04;9(3):
pubmed: 32143502
Neuropsychiatr Dis Treat. 2020 Feb 24;16:545-555
pubmed: 32158214
J Anxiety Disord. 2016 Jun;41:22-34
pubmed: 27259803
Medicina (Kaunas). 2021 Jun 10;57(6):
pubmed: 34200570
Brain Behav Immun. 2020 Jul;87:49-50
pubmed: 32304883
Front Physiol. 2021 Jan 18;11:623498
pubmed: 33536941
J Ment Health. 2021 Apr;30(2):156-163
pubmed: 33502917
Annu Rev Psychol. 2010;61:679-704
pubmed: 19572784
Eur J Clin Invest. 2020 Dec;50(12):e13423
pubmed: 33026101
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Epidemiol Health. 2020;42:e2020038
pubmed: 32512661
Psychoneuroendocrinology. 2021 May;127:105200
pubmed: 33740587
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
Schizophr Bull. 2018 Aug 20;44(5):973-982
pubmed: 29648618
BMJ. 2020 Jan 28;368:m313
pubmed: 31992552
JAMA. 2020 Dec 8;324(22):2251-2252
pubmed: 33206133
Int J Environ Res Public Health. 2020 Sep 25;17(19):
pubmed: 32992807
Sci Rep. 2020 Dec 10;10(1):21613
pubmed: 33303885

Auteurs

Ion Papava (I)

Department of Neurosciences-Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Center for Cognitive Research in Neuropsychiatric Pathology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Department of Psychiatry, Timis County Emergency Clinical Hospital "Pius Brinzeu", Liviu Rebreanu 156, 300723 Timisoara, Romania.

Liana Dehelean (L)

Department of Neurosciences-Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Center for Cognitive Research in Neuropsychiatric Pathology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Department of Psychiatry, Timis County Emergency Clinical Hospital "Pius Brinzeu", Liviu Rebreanu 156, 300723 Timisoara, Romania.

Radu Stefan Romosan (RS)

Department of Neurosciences-Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Center for Cognitive Research in Neuropsychiatric Pathology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Department of Psychiatry, Timis County Emergency Clinical Hospital "Pius Brinzeu", Liviu Rebreanu 156, 300723 Timisoara, Romania.

Mariana Bondrescu (M)

Department of Neurosciences-Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Department of Psychiatry, Timis County Emergency Clinical Hospital "Pius Brinzeu", Liviu Rebreanu 156, 300723 Timisoara, Romania.
Doctoral School, University of Medicine and Pharmacy "Victor Babes" Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Cristian Zoltan Dimeny (CZ)

Department of Psychiatry, Timis County Emergency Clinical Hospital "Pius Brinzeu", Liviu Rebreanu 156, 300723 Timisoara, Romania.

Eugenia Maria Domuta (EM)

Surgery Department, Faculty of Medicine and Pharmacy, University of Oradea, Piata 1 Decembrie 10, 410073 Oradea, Romania.

Felix Bratosin (F)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Iulia Bogdan (I)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Mirela Loredana Grigoras (ML)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Anatomy and Embryology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Codruta Victoria Tigmeanu (CV)

Department of Technology of Materials and Devices in Dental Medicine, Multidisciplinary Center for Research, Evaluation, Diagnosis and Therapies in Oral Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Angelica Gherman (A)

Research Center for Medical Communication, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Iosif Marincu (I)

Surgery Department, Faculty of Medicine and Pharmacy, University of Oradea, Piata 1 Decembrie 10, 410073 Oradea, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH